Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

Improvements seen across all six DLQI Domains indicating broad, beneficial impact on quality of life -- Data further demonstrates ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

—The identification of chronic spontaneous urticaria (CSU) endotypes has improved understanding of the heterogeneity of the disease and the underlying pathogenic mechanisms to inform diagnosis and ...

The authors noted that both chronic urticaria and IBS are primarily clinical diagnoses rather than conditions confirmed by ...

Despite its relevance to prognosis and treatment response, baseline disease duration is inconsistently reported in phase 3 clinical trials for chronic spontaneous urticaria (CSU), ...

Please provide your email address to receive an email when new articles are posted on . Barzolvolimab binds receptor tyrosine kinase KIT to inhibit its activity, which mast cells need for survival.

A massive global study has ranked the best and safest treatments for chronic hives when antihistamines fall short. The findings provide a clear treatment roadmap for both patients and clinicians alike ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Barzolvolimab prevents the binding of stem cell factor ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

Improvements seen across all six DLQI Domains indicating broad, beneficial impact on quality of life -- Data further ...